Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler M Seibert

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Prostate Cancer and Prostatic Diseases|June 15, 2021
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24Roshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
European Journal of Human Genetics : EJHG|June 10, 2020
The effect of sample size on polygenic hazard models for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2020
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population DataMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Scientific Data|January 27, 2026
The 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) datasetDominic LaBella, Katherine Schumacher, Michael Mix, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Prostate Cancer and Prostatic Diseases|June 15, 2021
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24Roshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
European Journal of Human Genetics : EJHG|June 10, 2020
The effect of sample size on polygenic hazard models for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2020
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population DataMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Scientific Data|January 27, 2026
The 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) datasetDominic LaBella, Katherine Schumacher, Michael Mix, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Pageof 14